What Does Echo Therapeutics Do?

Total employees8
HeadquartersBala Cynwyd
FoundedN/A

Echo Therapeutics, Inc. was a medical technology company focused on developing non-invasive continuous glucose monitoring (CGM) systems for people with diabetes and for use in hospital critical care units. Its lead product candidate was the Symphony tCGM System, designed to provide needle-free glucose readings through the skin using ultrasound and a sensor. The company also developed the Prelude SkinPrep System, a device designed to prepare the skin for transdermal drug delivery by removing the outer layer of the stratum corneum. Despite early promise and technological development, Echo Therapeutics faced significant financial and operational challenges, ultimately leading to a Chapter 7 bankruptcy filing in December 2016. In 2017, its intellectual property and other assets were acquired by an affiliate of Platinum Equity. The company is no longer operating as an independent entity.

Where Is Echo Therapeutics's Headquarters?

HQ Function

Former corporate headquarters, housing executive leadership, administrative functions, and coordinating research and development efforts for its non-invasive medical devices.

Notable Features:

The headquarters likely consisted of standard office spaces and potentially laboratory facilities appropriate for a medical device development company. No specific architectural highlights are widely publicized.

Work Culture:

As a development-stage medical technology company, the work culture was likely characterized by innovation, a focus on research and clinical trials, and a drive to bring its novel glucose monitoring technology to market. This would have involved a multidisciplinary team of scientists, engineers, and business professionals working in a dynamic, and likely challenging, environment.

HQ Significance:

This location served as the central hub for strategic decision-making, financial management, and the coordination of product development and clinical activities during the later stages of the company's operations before it ceased.

Values Reflected in HQ: The company's mission, and by extension its operational spaces, would have aimed to reflect values such as innovation in patient care, scientific rigor in product development, and a commitment to addressing the needs of individuals with diabetes and healthcare providers.

Location:

Echo Therapeutics was primarily focused on the United States market for its product development, clinical trials, and initial commercialization strategy. While potential for international expansion may have been considered as a long-term goal, significant global operations or a widespread international presence were not substantially established before the company ceased its primary activities and filed for bankruptcy. Its efforts were concentrated on gaining regulatory approvals, like FDA clearance, within the US.

Street Address:

One Presidential Boulevard North, Suite 402

City:

Bala Cynwyd

State/Province:

PA

Country:

USA

Where Else Does Echo Therapeutics Operate Around the World?

Nutley, NJ/USA

Address: 100 Metro Boulevard, Suite 250, Nutley, New Jersey 07110 (Former HQ)

Served as the primary operational base during a specific period of the company's history, focusing on its core business of medical device development.

Franklin, MA/USA

Address: 150 Bodwell Street Extension, Avon, MA 02322 (Previously Sontra Medical, later Echo manufacturing/R&D)

Focused on the technical development, engineering, and potentially small-scale production or assembly of its medical device systems.

Buying Intent Signals for Echo Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Echo Therapeutics? Meet the Executive Team

As of April 2025, Echo Therapeutics' leadership includes:

Scott W. Laronge - Former Chairman and Chief Executive Officer
R. Scott Horman - Former Chief Financial Officer
Patrick T. Mooney - Former Chairman and Chief Executive Officer (prior to Laronge)

Who's Investing in Echo Therapeutics?

Echo Therapeutics has been backed by several prominent investors over the years, including:

Publicly Traded (NASDAQ: ECTE, prior to delisting)
Pharmaceutical Product Development, LLC (PPD) (Significant historical stockholder)
Various individual and institutional investors through public markets and private placements during its operational years.

What Leadership Changes Has Echo Therapeutics Seen Recently?

Hire0
Exits0

Echo Therapeutics ceased active operations and filed for bankruptcy in December 2016. Therefore, there have been no executive new hires or exits in the last 12 months related to its former operational structure. The company's assets were acquired by Platinum Equity in 2017.

What Technology (Tech Stack) Is Used byEcho Therapeutics?

Discover the tools Echo Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Echo Therapeutics Email Formats and Examples

Given that Echo Therapeutics is no longer operational and its domain is inactive, the following email formats are based on common structures used by companies and are purely historical/speculative. These formats would no longer be active.

f[last]@echotherapeutics.com (e.g., jdoe@echotherapeutics.com) or [first].[last]@echotherapeutics.com (e.g. jane.doe@echotherapeutics.com)

Format

jdoe@echotherapeutics.com

Example

0 (domain inactive)%

Success rate

What's the Latest News About Echo Therapeutics?

Platinum Equity / PR NewswireFebruary 1, 2017

Platinum Equity Acquires Assets of Echo Therapeutics

An affiliate of Platinum Equity announced it had acquired the key assets of Echo Therapeutics, Inc., including its intellectual property portfolio and its Symphony and Prelude product technology. This followed Echo Therapeutics' bankruptcy....more

GlobeNewswireDecember 7, 2016

Echo Therapeutics, Inc. Files Voluntary Petition for Chapter 7 Bankruptcy

Echo Therapeutics announced that it filed a voluntary petition for relief under Chapter 7 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware. The company intended to pursue an orderly liquidation of its assets....more

PR NewswireOctober 13, 2015

Echo Therapeutics Announces Positive Results from a Human Clinical Trial of its Next-Generation CGM Sensor

Echo Therapeutics reported positive results from a human clinical trial of its next-generation wireless continuous glucose monitoring (CGM) sensor. This news, from when the company was actively developing its technology, highlighted its efforts in advancing non-invasive glucose monitoring....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Echo Therapeutics, are just a search away.